Clinical Trial

Effectiveness of Infiltrations in the Treatment of Plantar Fasciopathy

Study acronym: INFILTRA-PLANT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 4, 2024 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This clinical study aims to evaluate the effectiveness of infiltrations in the treatment of plantar fasciopathy, a painful condition that affects the sole of the foot and is common in active people. Plantar fasciopathy is caused by inflammation or damage to the plantar fascia, the tissue that connects the heel to the toes. Participants in this study will be randomly assigned to receive one of two treatments: corticosteroid infiltrations or conservative treatment without infiltrations. Infiltrations will be guided by ultrasound to ensure accuracy. The study will evaluate pain reduction and improvement in foot function over a six-month period. The objective of the study is to determine if infiltrations provide a significant improvement compared to other non-invasive treatments. The results will help doctors and patients make informed decisions about the best treatment options for plantar fasciopathy.
Trial Details
NCT Number NCT06671223
Lead Sponsor University of Seville
Conditions Plantar Fasciitis of Both Feet, Plantar Fasciopathy
Enrollment 200 participants
Start Date 2025-06-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-04